John Pena - Chief Executive Officer
John Pena is a co-founder and the CEO of QDTI. He is a seasoned high tech entrepreneur, executive and investment professional. With an emphasis on early stage ventures, he has a proven track record of building physical and biological science companies based on academic research-developed technologies.
Seabron Adamson - Chief Financial Officer
QDTI Co-founder and CFO Seabron Adamson has over two decades of experience in consulting and investment management, and has started two successful consulting companies. His original background is in optical physics.
Colin Connolly - Lead Scientist- Physics
Colin Connolly was a Co-founder of QDTI and has driven the development of the magnetic imager technology for the diagnostics application. He received the Ph.D. degree in Physics from Harvard University in 2013.
Jeff Randall - Lead Scientist - Assay Biochemistry
Jeff Randall, QDTI’s Director of Assay Technologies, is a veteran of the medicall diagnostics industry. At QDTI he has developed a new generation of diagnostic assays to pair with QDTI's advanced quantum sensing technology platform. He holds a Ph.D. in Cell, Molecular and Developmental Biology from Tufts University..
Scientific Advisory Board
Mikhail Lukin - Chairman
Mikhail Lukin has been a Professor of Physics at Harvard since 2004, where he is a co-Director of Harvard-MIT Center for Ultracold Atoms. He is an internationally recognized expert in quantum optics, NV center physics and quantum information science. His research interests include quantum control of atomic and nanoscale solid-state systems, quantum metrology, quantum nanophotonics, and quantum information science. He has co-authored over 300 technical papers and has received a number of major physics awards. He is a fellow of the OSA, APS, and AAAS.
Hongkun Park is Professor of Chemistry and Chemical Biology and Professor of Physics at Harvard University. He is also an Institute Member of the Broad Institute of MIT and Harvard. Professor Park is renowned for his pioneering work on quantum optoplasmonics and nano-bio interfacing. He is a recipient of Ho-Am Prize in Science and NIH Director’s Pioneer Award.
Ronald Walsworth is a Senior Lecturer on Physics at Harvard University and a Senior Physicist at the Smithsonian Institution. Dr. Walsworth has conducted extensive research on NV-center based sensing, and led the application of NV sensing technologies to neuroscience through his affiliation with the Center for Brain Science at Harvard. He received the Pipkin Award from APS for his work in precision measurements and bioimaging.
The QDTI team combines leading quantum scientists with experts from the biomedical and diagnostics industry